Clinical trial
Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
NCT00418639 · Romark Laboratories L.C., Industry · Completed
Key facts
| NCT number | NCT00418639 |
|---|---|
| Title | Study of Nitazoxanide in the Treatment of Chronic Hepatitis C |
| Official title | Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide in the Treatment of Chronic Hepatitis C |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Nitazoxanide |
| Enrollment | 50 |
| Start date | Feb 1, 2005 |
| First posted | Jan 5, 2007 |
| Last update posted | Jan 5, 2007 |
| Countries | Egypt |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: